Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2009-09-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/jama.2009.1346PMID 19755700
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dysfunctional high-density lipoprotein

  2009cited by this paper
• Letter by Thum et al regarding article, "Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone".

  2008cited by this paper
• Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.

  2008cited by this paper
• Paraoxonases (PON1, PON2, PON3) analyses in vitro and in vivo in relation to cardiovascular diseases.

  2008cited by this paper
• Contemporary Reviews in Cardiovascular Medicine Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases

  2008cited by this paper
• Multiple actions of high-density lipoprotein

  2008cited by this paper
• Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus.

  2008cited by this paper
• Hughes syndrome

  2007cited by this paper
• The paradox of dysfunctional high-density lipoprotein

  2007cited by this paper
• Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis

  2007cited by this paper
• Oxidant Stress Impairs In Vivo Reendothelialization Capacity of Endothelial Progenitor Cells From Patients With Type 2 Diabetes Mellitus: Restoration by the Peroxisome Proliferator-Activated Receptor-&ggr; Agonist Rosiglitazone

  2007cited by this paper
• Mechanisms of Disease: atherosclerosis in autoimmune diseases

  2006cited by this paper
• Antiphospholipid antibodies as a possible risk factor for atherosclerosis in patients with rheumatoid arthritis.

  2006cited by this paper
• Accelerated atheroma in the antiphospholipid syndrome.

  2006cited by this paper
• Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases.

  2006cited by this paper
• Non-invasive assessment of endothelial function: which technique?

  2006cited by this paper
• Antibodies Against β2-Glycoprotein I Complexed With an Oxidised Lipoprotein Relate to Intima Thickening of Carotid Arteries in Primary Antiphospholipid Syndrome

  2006cited by this paper
• Primary antiphospholipid syndrome: a distinct entity?

  2006cited by this paper
• Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model.

  2005cited by this paper
• Early Structural and Functional Changes of the Vasculature in HIV-Infected Children: Impact of Disease and Antiretroviral Therapy

  2005cited by this paper
• Antiphospholipid antibodies and atherosclerosis.

  2004cited by this paper
• Prognostic Value of Systemic Endothelial Dysfunction in Patients With Acute Coronary Syndromes: Further Evidence for the Existence of the “Vulnerable” Patient

  2004cited by this paper
• Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data

  2004cited by this paper
• Peripheral vascular disease in antiphospholipid syndrome.

  2004cited by this paper
• Anti-phospholipid antibodies and carotid-artery intima-media thickness in young survivors of myocardial infarction.

  2003cited by this paper
• Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.

  2003cited by this paper
• Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome

  2003cited by this paper
• Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis?

  2003cited by this paper
• Increased carotid artery intima-media thickness as an indicator of the onset of atherosclerosis in patients with connective tissue systemic diseases.

  2003cited by this paper
• Inflammatory/Antiinflammatory Properties of High-Density Lipoprotein Distinguish Patients From Control Subjects Better Than High-Density Lipoprotein Cholesterol Levels and Are Favorably Affected by Simvastatin Treatment

  2003cited by this paper
• Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.

  2002cited by this paper
• Decreased Atherosclerotic Lesion Formation in Human Serum Paraoxonase Transgenic Mice

  2002cited by this paper
• Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies

  2002cited by this paper
• High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

  2001cited by this paper
• Atherosclerosis and autoimmunity

  2001cited by this paper
• High-Density Lipoprotein Loses Its Anti-Inflammatory Properties During Acute Influenza A Infection

  2001cited by this paper
• Paraoxonase activity is dramatically decreased in patients positive for anticardiolipin antibodies

  2000cited by this paper
• Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

  1998cited by this paper
• Fequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE

  1998cited by this paper
• Massive Lower Extremity Arterial Thrombosis and Acute Hepatic Insufficiency in a Young Adult with Premature Atherosclerosis Associated with Hyperlipoprotein(a)emia and Antiphospholipid Syndrome

  1995cited by this paper
• Atherosclerosis and autoimmunity.

  1994cited by this paper

• Insights to HDL dysfunctionality: hypothesis of exhausted HDL.

  2026cites this paper
• Genetic determinants of arterial thrombosis in primary antiphospholipid syndrome: a systematic review

  2026cites this paper
• Extracellular Vesicles Analysis as Possible Signatures of Antiphospholipid Syndrome Clinical Features

  2025cites this paper
• Antiphospholipid Antibody Persistent Positivity Is Associated with Worsened Endothelial Dysfunction in Hemodialysis Patients: A Cross-Sectional Study

  2025cites this paper
• Pleiotropic functions and clinical importance of circulating HDL-PON1 complex.

  2024cites this paper
• Intima media thickness of the carotid artery in primary antiphospholipid syndrome: A systematic review and meta-analysis.

  2024cites this paper
• Can HDL cholesterol be replaced by paraoxonase 1 activity in the prediction of severe coronary artery disease in patients with type 2 diabetes?

  2023cites this paper
• Natural supplements in antiphospholipid syndrome: A case for further study.

  2023cites this paper
• Oxidative Stress as a Regulatory Checkpoint in the Production of Antiphospholipid Autoantibodies: The Protective Role of NRF2 Pathway

  2023cites this paper
• Augmented oxidative stress, accumulation of DNA damage and impaired DNA repair mechanisms in thrombotic primary antiphospholipid syndrome.

  2023cites this paper
• Arterial stiffness tested by pulse wave velocity and augmentation index for cardiovascular risk stratification in antiphospholipid syndrome

  2023influential citation
• Risk of subclinical atherosclerosis in patients with antiphospholipid syndrome and subjects with antiphospholipid antibody positivity: A systematic review and meta-analysis.

  2023cites this paper
• Non-invasive imaging in antiphospholipid syndrome to assess subclinical coronary artery disease.

  2023cites this paper
• Asthmatics with High Serum Amyloid A have Pro-inflammatory HDL: Implications for Augmented Systemic and Airway Inflammation.

  2023cites this paper
• HDL and Endothelial Function.

  2022cites this paper
• Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis.

  2022cites this paper
• Risk for Behçet’s disease gauged via high-density lipoprotein cholesterol: a nationwide population-based study in Korea

  2022cites this paper
• CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I Trial

  2022cites this paper
• Crosstalk between high-density lipoproteins and endothelial cells in health and disease: Insights into sex-dependent modulation

  2022cites this paper
• Arylesterase activity of paraoxonase 1 in patients with primary hypertension

  2021cites this paper
• Pathophysiology of Antiphospholipid Syndrome

  2021cites this paper
• Oxidative Stress in the Pathogenesis of Antiphospholipid Syndrome: Implications for the Atherothrombotic Process

  2021cites this paper
• Cardiovascular disease in lupus

  2021cites this paper
• Scavenger Receptor BI Induced by HDL From Coronary Heart Disease May Be Related to Atherosclerosis

  2021cites this paper
• Association between plasmatic oxidative stress and thrombosis in primary antiphospholipid syndrome

  2021cites this paper
• The Endothelium Is Both a Target and a Barrier of HDL’s Protective Functions

  2021cites this paper
• Therapeutic Potential and Immunomodulatory Role of Coenzyme Q10 and Its Analogues in Systemic Autoimmune Diseases

  2021cites this paper
• Artemisinin analogue SM934 protects against lupus-associated antiphospholipid syndrome via activation of Nrf2 and its targets

  2021cites this paper
• Abdominal arterial lesions associated with antiphospholipid antibodies: A comparative cross sectional magnetic resonance angiography study.

  2021cites this paper
• Cardiovascular Disease in Systemic Lupus Erythematosus

  2021cites this paper
• Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots

  2021cites this paper
• Thrombosis and Haemostasis Pathophysiology of the Antiphospholipid Antibody Syndrome

  2021cites this paper
• High-density lipoprotein functionality in systemic lupus erythematosus.

  2020cites this paper
• Unsupervised Integrated Transcriptomic Analyses Define Atherothrombotic Risk in Primary Antiphospholipid Syndrome.

  2020cites this paper
• Association of systemic lupus erythematosus with peripheral arterial disease: a meta-analysis of literature studies.

  2020cites this paper
• The HDL dysfunction gains momentum: is it time for a new approach in rheumatic diseases?

  2020cites this paper
• New insights into antiphospholipid-related endothelial dysfunction by assessment of vascular glycocalyx layer: results from a preliminary cross-sectional study

  2020cites this paper
• Advances in HDL: Much More than Lipid Transporters

  2020cites this paper
• Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders

  2020cites this paper
• NETs in APS: Current Knowledge and Future Perspectives

  2020cites this paper
• HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns study

  2020cites this paper
• Mutual Influences between Nitric Oxide and Paraoxonase 1

  2019cites this paper
• Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction

  2019cites this paper
• Vasoprotective Functions of High-Density Lipoproteins Relevant to Alzheimer’s Disease Are Partially Conserved in Apolipoprotein B-Depleted Plasma

  2019cites this paper
• High-Density Lipoprotein Function and Dysfunction in Health and Disease

  2019cites this paper
• Effects of high-density lipoprotein from patients with chronic kidney disease on endothelial function

  2019cites this paper
• Antiphospholipid Syndrome

  2019cites this paper
• Dysfunctional HDL as a Therapeutic Target for Atherosclerosis Prevention.

  2019cites this paper
• Humoral immunity against HDL particle: a new perspective in cardiovascular diseases?

  2019cites this paper
• A Simplified Understanding of the Black Swan: Anti-phospholipid Antibody Syndrome

  2019cites this paper
• Cardiac Manifestations of Antiphospholipid Syndrome: Clinical Presentation, Role of Cardiac Imaging, and Treatment Strategies

  2019cites this paper
• Correlation of Paraoxonase-1 with the Severity of Crohn’s Disease

  2018cites this paper
• Apolipoprotein A-I Reduces In-Stent Restenosis and Platelet Activation and Alters Neointimal Cellular Phenotype

  2018cites this paper
• Development of a thrombin generation test in cultured endothelial cells: Evaluation of the prothrombotic effects of antiphospholipid antibodies.

  2018cites this paper
• High-Density Lipoproteins and Apolipoprotein A-I Improve Stent Biocompatibility.

  2018cites this paper
• HDL ( High-Density Lipoproteins ) and Apo ( Apolipoprotein ) A-I Improve Stent Biocompatibility Recent Evidence From Experimental Models and Clinical Studies

  2018cites this paper
• Oxidative post-translational modification of βeta 2-glycoprotein I in the pathophysiology of the anti-phospholipid syndrome.

  2018cites this paper
• Cardiovascular Disease Risk in Women: What Makes It Different from Men

  2017cites this paper
• Inflamación y respuesta inmune innata: participación de las lipoproteínas de alta densidad

  2017cites this paper
• Neuropsychiatric Manifestations of Antiphospholipid Syndrome

  2017cites this paper
• Antiphospholipid Syndrome: Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics.

  2017cites this paper
• Antiphospholipid Antibody Syndrome in Childhood

  2017cites this paper
• New Insights in the Pathophysiology of Antiphospholipid Syndrome

  2017cites this paper
• Extended‐release niacin increases anti‐apolipoprotein A‐I antibodies that block the antioxidant effect of high‐density lipoprotein–cholesterol: the EXPLORE clinical trial

  2017cites this paper
• Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study.

  2017cites this paper
• Ubiquinol Effects on Antiphospholipid Syndrome Prothrombotic Profile: A Randomized, Placebo-Controlled Trial

  2017cites this paper
• Anti-inflammatory treatment improves high-density lipoprotein function in rheumatoid arthritis

  2016cites this paper
• Diploma thesis Identification of antigen-specific natural killer T cells in patients with antiphospholipid antibody syndrome

  2016cites this paper
• Why are kids with lupus at an increased risk of cardiovascular disease?

  2016cites this paper
• Endothelin 1, ADMA and SDMA in pregnancies with obstetric and thrombotic antiphospholipid syndrome.

  2016cites this paper
• Intérêt du test de génération de thrombine dans le syndrome des antiphospholipides

  2016cites this paper
• Análisis de los mecanimos celulares y moleculares reguladores del efecto de la Fluvastatina y nuevos fármacos antioxidantes en la prevención de la trombosis y la aeterotrombosis asociadas al Síndrome Antifosfolipido y al Lupus Eritematoso Sistémico. Estudio Genómico y Proteómico

  2016cites this paper
• Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approaches.

  2016cites this paper
• Inflammation in arterial diseases

  2015cites this paper
• Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk.

  2015cites this paper
• Interaction between HDL and inflammation: When the good turns to be bad.

  2015cites this paper
• The Pathophysiology of Antiphospholipid Syndrome

  2015cites this paper
• Infliximab improves endothelial dysfunction in a mouse model of antiphospholipid syndrome: Role of reduced oxidative stress.

  2015cites this paper
• Dysfunctional HDL: from structure-function-relationships to biomarkers.

  2015cites this paper
• Structural and functional changes in HDL with low grade and chronic inflammation.

  2015cites this paper
• Biomarkers for cardiovascular risk assessment in autoimmune diseases

  2015cites this paper
• Obesity and Antiphospholipid Syndrome: A Particular Challenge in Pregnancy

  2015cites this paper
• Reproducibility and biological variability of HDL's vascular functional assays.

  2015cites this paper
• FACULTE DE MEDECINE ET DE PHARMACIE DE ROUEN

  2015cites this paper
• Immunotherapy in antiphospholipid syndrome.

  2015cites this paper
• Antiphospholipid Antibodies Attenuate Endothelial Repair and Promote Neointima Formation in Mice

  2014cites this paper
• A Closer Look at Cardioprotective Function of HDL: Revise the HDL – Cholesterol Hypothesis?

  2014cites this paper
• Pathogenesis and treatment of atherosclerosis in lupus.

  2014cites this paper
• Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus

  2014cites this paper
• HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction.

  2014cites this paper
• Apolipoprotein a-I at the interface of vascular inflammation and arthritis.

  2014cites this paper
• Endothelial Dysfunction in Chronic Inflammatory Diseases

  2014cites this paper
• The Clinical Significance of Posttranslational Modification of Autoantigens

  2014cites this paper
• Vertebral artery thrombosis: a rare presentation of primary polycythaemia

  2014cites this paper
• Intérêt d'un nouvel outil d'évaluation de la microcirculation et du glycocalyx endothélial en médecine interne : résultats préliminaires dans la sclérodermie systémique et le syndrome des antiphospholipides

  2014cites this paper
• [Assessment of endothelial function in autoimmune diseases].

  2014cites this paper
• Markers of cardiovascular risk in patients with antiphospholipid syndrome: A meta-analysis of literature studies

  2014cites this paper
• Thrombophilic states.

  2014cites this paper
• treatment 10 in the pathogenesis of the disease and effects of coenzyme Q Mitochondrial dysfunction in antiphospholipid syndrome: implications

  2014cites this paper
• Évaluation de la fonction endothéliale au cours des maladies auto-immunes

  2014cites this paper